Cargando…

Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective()

The coronavirus disease 2019 (COVID-19) produced by SARS-CoV-2 has taken on great importance in recent months, and is under constant investigation by different areas of medicine, including rheumatology, in search of the best scientific evidence. In the case of the pediatric population, it is particu...

Descripción completa

Detalles Bibliográficos
Autores principales: Naranjo Arango, Yonatan Andrés, Farfán Cortés, Abraham Yamit Amin Ariff, García Henao, Juan Pablo, Arango Slingsby, Christine, Saldarriaga Rivera, Lina María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526434/
http://dx.doi.org/10.1016/j.rcreue.2020.09.004
_version_ 1784585865462284288
author Naranjo Arango, Yonatan Andrés
Farfán Cortés, Abraham Yamit Amin Ariff
García Henao, Juan Pablo
Arango Slingsby, Christine
Saldarriaga Rivera, Lina María
author_facet Naranjo Arango, Yonatan Andrés
Farfán Cortés, Abraham Yamit Amin Ariff
García Henao, Juan Pablo
Arango Slingsby, Christine
Saldarriaga Rivera, Lina María
author_sort Naranjo Arango, Yonatan Andrés
collection PubMed
description The coronavirus disease 2019 (COVID-19) produced by SARS-CoV-2 has taken on great importance in recent months, and is under constant investigation by different areas of medicine, including rheumatology, in search of the best scientific evidence. In the case of the pediatric population, it is particularly important as it was first thought that the impact of the pandemic in this population would be less due to the low presence of severe cases. Evidence is now being reported of clinical pictures in children with a diagnosis of COVID-19 who are characterized by an altered inflammatory state consisting of a storm of pro-inflammatory cytokines that produces manifestations similar to those presented in autoimmune diseases, such as Kawasaki disease. It has been called Multisystemic Inflammatory Syndrome in children, temporarily associated with SARS-CoV-2 which, in many cases requires hospitalization in pediatric intensive care units and multidisciplinary management by various specialties.
format Online
Article
Text
id pubmed-8526434
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-85264342021-10-20 Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective() Naranjo Arango, Yonatan Andrés Farfán Cortés, Abraham Yamit Amin Ariff García Henao, Juan Pablo Arango Slingsby, Christine Saldarriaga Rivera, Lina María Revista Colombiana de Reumatología (English Edition) Review Article The coronavirus disease 2019 (COVID-19) produced by SARS-CoV-2 has taken on great importance in recent months, and is under constant investigation by different areas of medicine, including rheumatology, in search of the best scientific evidence. In the case of the pediatric population, it is particularly important as it was first thought that the impact of the pandemic in this population would be less due to the low presence of severe cases. Evidence is now being reported of clinical pictures in children with a diagnosis of COVID-19 who are characterized by an altered inflammatory state consisting of a storm of pro-inflammatory cytokines that produces manifestations similar to those presented in autoimmune diseases, such as Kawasaki disease. It has been called Multisystemic Inflammatory Syndrome in children, temporarily associated with SARS-CoV-2 which, in many cases requires hospitalization in pediatric intensive care units and multidisciplinary management by various specialties. Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2021 2021-10-20 /pmc/articles/PMC8526434/ http://dx.doi.org/10.1016/j.rcreue.2020.09.004 Text en © 2020 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Naranjo Arango, Yonatan Andrés
Farfán Cortés, Abraham Yamit Amin Ariff
García Henao, Juan Pablo
Arango Slingsby, Christine
Saldarriaga Rivera, Lina María
Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective()
title Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective()
title_full Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective()
title_fullStr Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective()
title_full_unstemmed Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective()
title_short Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective()
title_sort multisystemic inflammatory syndrome in children with covid-19: a rheumatology perspective()
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526434/
http://dx.doi.org/10.1016/j.rcreue.2020.09.004
work_keys_str_mv AT naranjoarangoyonatanandres multisystemicinflammatorysyndromeinchildrenwithcovid19arheumatologyperspective
AT farfancortesabrahamyamitaminariff multisystemicinflammatorysyndromeinchildrenwithcovid19arheumatologyperspective
AT garciahenaojuanpablo multisystemicinflammatorysyndromeinchildrenwithcovid19arheumatologyperspective
AT arangoslingsbychristine multisystemicinflammatorysyndromeinchildrenwithcovid19arheumatologyperspective
AT saldarriagariveralinamaria multisystemicinflammatorysyndromeinchildrenwithcovid19arheumatologyperspective